Prenatal screening for sex chromosome aneuploidies (SCAs) is increasingly available
through expanded non‐invasive prenatal testing (NIPT). NIPT for SCAs raises complex …

We performed a systematic review of factors affecting parental decisions to continue or
terminate a pregnancy after prenatal diagnosis of a sex chromosome abnormality, as …

Abstract Context: Klinefelter syndrome (KS; 47, XXY karyotype and variants) is characterized
by tall stature and testicular failure, with marked variation in severity of the phenotype …

Objective To investigate the rate of pregnancy termination for various fetal aneuploidies, and
to evaluate predictors of this choice. Methods A retrospective cohort study identified all …

This study aims to assess prevalence and pregnancy outcome for sex chromosome
trisomies (SCTs) diagnosed prenatally or in the first year of life. Data held by the European …

Cell‐free DNA (cfDNA) testing is increasingly being used to screen pregnant women for fetal
aneuploidies. This technology may also identify fetal sex and can be used to screen for sex …

Background: Girls with Turner syndrome (TS) have a high incidence of primary ovarian
insufficiency. Recent data show rates of spontaneous thelarche (ST) of 38% and …

Sex chromosome aneuploidies (SCAs) occur in 1 in every 400 births. SCAs are highly
variable and have uncertain prognoses, complicating the delivery of prenatal cell‐free DNA …

Objective: To assess the performance of non-invasive prenatal testing (NIPT) in screening
sex chromosome aneuploidy (SCA), and explore prenatal decision-making in NIPT positive …

Objective To assess the performance of a directed chromosomal analysis approach in the
prenatal evaluation of fetal sex chromosome aneuploidy. Methods We analyzed 432 frozen …